CN105559074B - A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug - Google Patents
A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug Download PDFInfo
- Publication number
- CN105559074B CN105559074B CN201610077038.8A CN201610077038A CN105559074B CN 105559074 B CN105559074 B CN 105559074B CN 201610077038 A CN201610077038 A CN 201610077038A CN 105559074 B CN105559074 B CN 105559074B
- Authority
- CN
- China
- Prior art keywords
- tealeaves
- tea
- essential oil
- cancer
- volatile essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 31
- 239000002246 antineoplastic agent Substances 0.000 title claims abstract description 11
- 229940041181 antineoplastic drug Drugs 0.000 title claims abstract description 11
- 206010028980 Neoplasm Diseases 0.000 title abstract description 15
- 201000011510 cancer Diseases 0.000 title abstract description 15
- 230000036541 health Effects 0.000 title abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract description 48
- 235000013616 tea Nutrition 0.000 claims abstract description 31
- 235000009569 green tea Nutrition 0.000 claims abstract description 19
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 11
- 230000000694 effects Effects 0.000 claims abstract description 10
- 235000020279 black tea Nutrition 0.000 claims abstract description 7
- 238000004821 distillation Methods 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000020334 white tea Nutrition 0.000 claims abstract description 6
- 235000020338 yellow tea Nutrition 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 102000004960 NAD(P)H dehydrogenase (quinone) Human genes 0.000 abstract description 19
- 108020000284 NAD(P)H dehydrogenase (quinone) Proteins 0.000 abstract description 19
- 230000001093 anti-cancer Effects 0.000 abstract description 8
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000020333 oolong tea Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 241000233805 Phoenix Species 0.000 description 3
- 239000011149 active material Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001932 seasonal effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 150000001875 compounds Chemical group 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- XPPALVZZCMPTIV-ARJAWSKDSA-N Jasmine lactone Chemical compound CC\C=C/CC1CCCC(=O)O1 XPPALVZZCMPTIV-ARJAWSKDSA-N 0.000 description 1
- XPPALVZZCMPTIV-UHFFFAOYSA-N Jasmine lactone Natural products CCC=CCC1CCCC(=O)O1 XPPALVZZCMPTIV-UHFFFAOYSA-N 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000002841 anti-cancer assay Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000020339 pu-erh tea Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to tea processing field, discloses a kind of tealeaves volatile essential oil and preparing the application in cancer-preventing health product or anticancer drug.The cancer-preventing health product or anticancer drug refer to that prevention and treatment or treatment have the health care product or drug of the cancer of quinone reductase inductive effect.Tealeaves volatile essential oil is to be extracted using tealeaves as raw material by Simultaneous distillation.The tealeaves volatile essential oil of acquisition not only has the smell of pleasant, can releive anxiety, but also there is certain anticancer effect, 6 big teas include that the volatile essential oil concentration extracted of black tea, green tea, green tea, yellow tea, white tea and dark green tea can induce quinone reductase multiplication in the range of 3~30 μ g/ml and play antitumaous effect.Result of study shows that tealeaves volatile essential oil by inducing quinone reductase to play antitumaous effect, is a kind of potential anti-cancer active matter, can prepare cancer-preventing health product and anticancer drug.
Description
Technical field
The invention belongs to tealeaves intensive processing technical field, in particular to a kind of tealeaves volatile essential oil is protected in preparation anti-cancer
Application in strong product or anticancer drug.
Background technique
Chinese tea drinking is with a long history, and Resources of Tea Plant is abundant, this provides advantageous condition for the person of drinking tea.Tea be most by
One of the healthy beverage that people welcome, contains a variety of function such as tea albumen, tea polyphenols, tea polysaccharide, caffeine, tea saponin in tealeaves
Ingredient is imitated, there are the physiological functions such as antitumor, hypoglycemic, reducing blood lipid, blood pressure lowering, anti-oxidant and enhancing immunity of organisms, as
Health food and drug have wide development prospect.
Tea aroma substance classes are abundant, and content is atomic, typically constitutes from the 0.01~0.05% of dry matter of tea content, green
Tea is about 0.005~0.02%, and black tea is about 0.01~0.03%, and oolong tea is about 0.05%.Tea aroma substance is by organic
Chemical classification can be divided into hydrocarbon, alcohols, aldehydes, ketone, acids, esters, lactone, phenols, oxa- class compound,
Sulfur-bearing class compound, containing nitrogen compound etc., wherein based on alcohols, ketone, esters, aldehydes and hydrocarbon.Fragrance contains
Highest oolong tea is measured, fragrance is because of home environment, tea tree breed, fresh leaf, manufacture craft, quality grade, storage method
Respective distinctive odor characteristic is shown Deng different, is affected especially with manufacture craft: attenuation degree less serious case, fragrance component
Middle nerolidol, jasmine lactone, indoles equal size are higher；Attenuation degree severe one, linalool and its oxidation product, geraniol, benzene
The component contents such as methanol are higher.In terms of tea comprehensive processing, Aqua Folium Camelliae sinensis extraction prepares instant tea, concentrated tea juice is processed for tea beverage
It is used widely, the tea polyphenols separated in tealeaves include that catechin therein is widely used in food additives or production health care food
Product, anticancer research even for field of medicaments such as anti-inflammatory drug and is done in part, but volatile essential oil, that is, aroma substance of tealeaves, protects
Health-care function is paid attention to using seldom work in-process.There is patent using hydro carbons and its derivative (it is derivative to be originated from grease) to 6 big tea
The volatile essential oil of class tealeaves has carried out the extraction of selectivity, prepares high fragrance after having patent to utilize correlation down enzymatic treatment tealeaves
Tea extract, there are also patents, and microwave coupled ion liquid to be utilized to carry out the extraction of tea aroma and for analyzing.
Summary of the invention
In order to solve the disadvantage that the prior art and shortcoming, the purpose of the present invention is to provide a kind of tealeaves volatility essences
Oil is preparing the application in cancer-preventing health product or anticancer drug.This method is simple, quickly.
The purpose of the present invention is achieved through the following technical solutions:
A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug.
The cancer-preventing health product or anticancer drug refer to that prevention and treatment or treatment have the cancer of quinone reductase (QR) inductive effect
The health care product or drug of disease.
The tealeaves volatile essential oil is preferably extracted by Simultaneous distillation using tealeaves as raw material.?
It can be prepared using other methods.
The Simultaneous distillation is specifically according to the following steps: tea raw material being ground, according to every gram of tealeaves original
The ratio of material addition 5~20ml water adds water, obtains tea mixture；Using methylene chloride as extractant, using distilling simultaneously
The methods of extraction equipment extracts, and extraction time is 60min~180min；Obtained solution is transferred to nitrogen in sample bottle to blow
It is dry, obtain tealeaves essential oil.
Described to be extracted specifically according to the following steps using SDE method: tea mixture is placed in round bottom burning
In bottle, it is connected to one end of distilling and extracting device, and heated with electric jacket, kept slightly boiled；The other end of distilling and extracting device connects
Tipping has the round-bottomed flask of methylene chloride, is heated with water-bath, temperature is maintained at 55 DEG C.
When tealeaves dosage≤50 gram, the dosage of the methylene chloride is 50mL；When 50 grams of tealeaves dosage >, described two
The dosage of chloromethanes is ml of tealeaves grams corresponding number.
The tealeaves is black tea, green tea, green tea, yellow tea, white tea and dark green tea.
The present invention induces its quinone reductase to by representative of murine hepatocarcinoma cell Hepa1c1c7 using tealeaves volatile essential oil
(QR) activity rises to anticancer activity evaluation, and tealeaves volatile essential oil there is preferable inhibition to make Hepa1c1c7 cancer cell line
With being a kind of potential cancer-resisting active material.
The present invention have the following advantages compared with prior art and the utility model has the advantages that
(1) present invention, which extracts obtained tealeaves volatile essential oil, has stronger cancer-preventing health and anticancer effect, and this hair
Operation is simple for Simultaneous distillation involved in bright and correlation method, at low cost, and the rate of recovery of essential oil is high；Therefore, have
Higher practical application and promotional value.
(2) the obtained tealeaves essential oil of the present invention can be applied in aromatotherapy, can not only relieving mood, eliminate burnt
Consider, and also there is the health-care efficacy for inhibiting growth of cancer cells, have a good application prospect, can be applied to medicine, health care
Product and daily use chemicals industry.
Specific embodiment
Below with reference to embodiment, the present invention is described in further detail, and embodiments of the present invention are not limited thereto.
The preparation method of 1 tealeaves volatile essential oil of embodiment
(1) it weighs 25g and grinds tea sample in 1L round-bottomed flask, according to the ratio of every gram of tea raw material addition 5~20ml water
Level-one water is added, is connected to one end of SDE method, and heated with electric jacket, is kept slightly boiled；Other end connection dress
There is the round-bottomed flask of 50mL methylene chloride, heated with water-bath, temperature is maintained at 55 DEG C；Extraction time is 60~180min.
(2) it collects distillate after extracting to be transferred in sample bottle, nitrogen, which is blown, volatilizes methylene chloride, obtains tealeaves volatility essence
Oil samples.
The research of 2 tealeaves volatile essential oil antitumor cell efficacy in vitro of embodiment, comprising the following steps:
(1) Hepa1c1c7 murine hepatocarcinoma cell suspension, logarithmic growth phase, cell in good condition, with 0.25% are prepared
Trypsase (mass percent) digestion, is configured to 5 × 10 with culture medium3The cell suspension of a cell/mL is inoculated in the training of 96 holes
It supports in plate, every 200 μ L of hole, is inoculated with two boards.37 DEG C, 5% (percentage by volume) CO2Cell is cultivated for 24 hours in incubator.
(2) tealeaves volatile essential oil is used to the a-MEM culture solution (volume basis for containing 10% fetal calf serum according to doses
Number) it is configured to certain concentration solution with sample, 150 μ L solution are added in every hole, will be added without murine hepatocarcinoma cell group as sky
White control group, control group add equivalent fresh medium.37 DEG C, 5%CO2Continue to cultivate cell in incubator (percentage by volume).
(3) after culture for 24 hours, two boards are divided into A plate and B plate.
The measurement of cell survival rate
The crystal violet of A plate 0.2% (mass percent) of addition, every 100 μ L of hole, (20-25 DEG C) placement 10-15min of room temperature,
Paper suck dry moisture is used after rinsing in water.0.5%SDS (mass percent) solution, the 100rpm on shaking table, 37 DEG C of oscillations are added
After 1h, absorbance value (OD value) is surveyed at 610nm with microplate reader.
The measurement of quinone reductase (QR)
The digitonin (mass percent) of 50 μ L 0.08% is added in B plate, on 100rpm shaking table, 37 DEG C of oscillations >
0.5h.Then by reaction system: being poured into loading slot after enzyme solution, MTT, menadione mixing, it is anti-to be rapidly added 200 μ L/well enzymes
Answer liquid.Using microplate reader using KINETIC METHOD in 490nm, 1min measurement is primary.
(4) calculation method
The opposite QR activity of sample indicates with CD value, and being defined as opposite QR activity, to reach corresponding sample when multiplication dense
Degree, when cell viability is greater than 0.5, and opposite QR activity is greater than 2, it is believed that there is sample the activity of induction quinone reductase to have
Anticancer activity.
The anticancer activity of 3 tealeaves essential oil of embodiment evaluates (one)
Black tea, green tea, dark green tea, white tea, green tea, the yellow tea method that totally 6 big teas representatives use embodiment 1 are obtained into tealeaves
Volatile essential oil obtains the tool that induction quinone reductase generates multiplication by linear fit curve using method as described in example 2
Bulk concentration.
The big teas tealeaves essential oil of table 1. 6 induces quinone reductase to generate the concentration (μ g/ml) to double
| Teas | Teas is tested to represent | QR multiplication concentration |
| Black tea | Big-leaf species in yunnan black tea | 5.32 |
| Green tea | Big-leaf species in yunnan green tea | 12.32 |
| Dark green tea | Big-leaf species in yunnan Pu'er tea | 3.03 |
| White tea | Fuding white tea | 8.96 |
| Green tea | Phoenix is single from (honey is blue fragrant) | 23.08 |
| Yellow tea | Hunan Junshan Silver Needle Tea | 7.39 |
Result above is the average value of parallel laboratory test three times
According to table 1 the result shows that: the tea of different teas volatilization oil concentration can induce quinone also in the range of 3~30 μ g/mL
Antitumaous effect is played in protoenzyme multiplication.Illustrate that tealeaves volatile essential oil is a kind of potential cancer-resisting active material.
The anticancer activity of 4 tealeaves essential oil of embodiment evaluates (two)
Different flavor Various Seasonal oolong tea (green tea) is obtained into tealeaves volatile essential oil using the method for embodiment 1, is made
With method as described in example 2, the specific concentration that induction quinone reductase generates multiplication is obtained by linear fit curve.
2. different flavor Various Seasonal phoenix Dan Congcha (green tea) of table etc. induces QR to generate the concentration (μ g/mL) to double
Result above is the average value of parallel laboratory test three times
According to table 2 the result shows that: the phoenix of different flavor Various Seasonal it is single from oolong tea volatilization oil concentration in 3~30 μ g/
It equally can induce quinone reductase multiplication in the range of mL and play antitumaous effect.Illustrate that tealeaves volatile essential oil is a kind of potential
Cancer-resisting active material.
The above embodiment is a preferred embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment
Limitation, other any changes, modifications, substitutions, combinations, simplifications made without departing from the spirit and principles of the present invention,
It should be equivalent substitute mode, be included within the scope of the present invention.
Claims (4)
1. a kind of tealeaves volatile essential oil is preparing the application in anticancer drug；The anticancer drug refers to that treatment has quinone reduction
The drug of the liver cancer of enzyme induction effect；The tealeaves volatile essential oil is to be mentioned using tealeaves as raw material by Simultaneous distillation
It obtains；The Simultaneous distillation is specifically according to the following steps: tea raw material being ground, according to every gram of tealeaves original
The ratio of material addition 5~20ml water adds water, obtains tea mixture；Using methylene chloride as extractant, using distilling simultaneously
Extraction equipment method extracts, and extraction time is 60min~180min；Obtained solution is transferred to nitrogen in sample bottle to dry up
It is dry, obtain tealeaves essential oil.
2. application according to claim 1, it is characterised in that: described to be extracted specifically using SDE method
According to the following steps: tea mixture sets the one end for being connected to distilling and extracting device in a round bottom flask, and is added with electric jacket
Heat is kept slightly boiled；The other end connection of distilling and extracting device is equipped with the round-bottomed flask of methylene chloride, is heated with water-bath, temperature
It is maintained at 55 DEG C.
3. application according to claim 1, it is characterised in that: when tealeaves dosage≤50 gram, the use of the methylene chloride
Amount is 50mL；When 50 grams of tealeaves dosage >, the dosage of the methylene chloride is ml of tealeaves grams corresponding number.
4. application according to claim 1, it is characterised in that: the tealeaves be black tea, green tea, green tea, yellow tea, white tea or
Dark green tea.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610077038.8A CN105559074B (en) | 2016-02-03 | 2016-02-03 | A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610077038.8A CN105559074B (en) | 2016-02-03 | 2016-02-03 | A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105559074A CN105559074A (en) | 2016-05-11 |
| CN105559074B true CN105559074B (en) | 2019-02-12 |
Family
ID=55870190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610077038.8A Active CN105559074B (en) | 2016-02-03 | 2016-02-03 | A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105559074B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109234016A (en) * | 2018-10-19 | 2019-01-18 | 福建农林大学 | A kind of tea tree ethereal oil preparation method with inhibition cancer cell multiplication effect |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113692A (en) * | 1994-06-20 | 1995-12-27 | 广东省微生物研究所 | Producing method for mineral tea drinks |
| CN1329498A (en) * | 1998-12-07 | 2002-01-02 | 艾科斯迈特技术公司 | Cancer treatment composition and method using natural plant essential oils |
| CN1408387A (en) * | 2001-09-19 | 2003-04-09 | 文维良 | Tea essence compound medicine and its preparing method |
| CN1476830A (en) * | 2003-07-17 | 2004-02-25 | 新疆特丰药业股份有限公司 | Tea-polyphenol soft capsule and its preparation process |
| CN1654614A (en) * | 2005-03-10 | 2005-08-17 | 中国农业大学 | Method for extracting garlic oil |
| EP2010196A2 (en) * | 2006-03-23 | 2009-01-07 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising green tea species |
| CN102550769A (en) * | 2010-12-24 | 2012-07-11 | 云南天士力帝泊洱生物茶集团有限公司 | Aromatic substance in tea leaves as well as extraction method and application of aromatic substance |
| CN103127232A (en) * | 2013-03-14 | 2013-06-05 | 赵晓昂 | Total extract for mulberry leaf prescription as well as preparation and usage thereof |
| CN103571613A (en) * | 2012-08-06 | 2014-02-12 | 湖北大自然农业实业有限公司 | Preparation method of vitex negundo linn volatile oil |
| CN103859098A (en) * | 2014-04-04 | 2014-06-18 | 绍兴御茶村茶业有限公司 | Preparation method for green tea type extract |
| CN104004593A (en) * | 2014-06-10 | 2014-08-27 | 河源市石坪顶茶业发展有限公司 | Extraction method of green tea essential oil |
| CN104586945A (en) * | 2014-12-05 | 2015-05-06 | 沈阳药科大学 | Hop total flavonoid extract as well as preparation method and application thereof in preparing medicines for preventing and treating liver injury and cancers |
| CN104611137A (en) * | 2015-01-16 | 2015-05-13 | 江汉大学 | Extraction method of chrysanthemum morifolium volatile oil |
| CN104745308A (en) * | 2015-03-23 | 2015-07-01 | 吉林化工学院 | Method for extracting white pepper volatile oil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102516344B (en) * | 2011-11-14 | 2013-07-10 | 浙江大学 | Compound with antitumor activity and preparation method and application thereof |
| CN103333217B (en) * | 2013-06-28 | 2015-05-20 | 浙江大学 | Compound having quinone reductase induced activity and preparation method thereof |
| CN103585485B (en) * | 2013-11-29 | 2015-06-24 | 西双版纳后世博文化传播有限公司 | Anticancer medicine and preparation method and application |
-
2016
- 2016-02-03 CN CN201610077038.8A patent/CN105559074B/en active Active
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113692A (en) * | 1994-06-20 | 1995-12-27 | 广东省微生物研究所 | Producing method for mineral tea drinks |
| CN1329498A (en) * | 1998-12-07 | 2002-01-02 | 艾科斯迈特技术公司 | Cancer treatment composition and method using natural plant essential oils |
| CN1408387A (en) * | 2001-09-19 | 2003-04-09 | 文维良 | Tea essence compound medicine and its preparing method |
| CN1476830A (en) * | 2003-07-17 | 2004-02-25 | 新疆特丰药业股份有限公司 | Tea-polyphenol soft capsule and its preparation process |
| CN1654614A (en) * | 2005-03-10 | 2005-08-17 | 中国农业大学 | Method for extracting garlic oil |
| EP2010196A2 (en) * | 2006-03-23 | 2009-01-07 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising green tea species |
| CN102550769A (en) * | 2010-12-24 | 2012-07-11 | 云南天士力帝泊洱生物茶集团有限公司 | Aromatic substance in tea leaves as well as extraction method and application of aromatic substance |
| CN103571613A (en) * | 2012-08-06 | 2014-02-12 | 湖北大自然农业实业有限公司 | Preparation method of vitex negundo linn volatile oil |
| CN103127232A (en) * | 2013-03-14 | 2013-06-05 | 赵晓昂 | Total extract for mulberry leaf prescription as well as preparation and usage thereof |
| CN103859098A (en) * | 2014-04-04 | 2014-06-18 | 绍兴御茶村茶业有限公司 | Preparation method for green tea type extract |
| CN104004593A (en) * | 2014-06-10 | 2014-08-27 | 河源市石坪顶茶业发展有限公司 | Extraction method of green tea essential oil |
| CN104586945A (en) * | 2014-12-05 | 2015-05-06 | 沈阳药科大学 | Hop total flavonoid extract as well as preparation method and application thereof in preparing medicines for preventing and treating liver injury and cancers |
| CN104611137A (en) * | 2015-01-16 | 2015-05-13 | 江汉大学 | Extraction method of chrysanthemum morifolium volatile oil |
| CN104745308A (en) * | 2015-03-23 | 2015-07-01 | 吉林化工学院 | Method for extracting white pepper volatile oil |
Non-Patent Citations (1)
| Title |
|---|
| 茶叶挥发性成分及其生物活性的研究;田光辉等;《食品科技》;20071220(第12期);第79页1.2.1挥发油的提取，第81页2.2两种挥发油对对？OH 的清除作用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105559074A (en) | 2016-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Majhenič et al. | Antioxidant and antimicrobial activity of guarana seed extracts | |
| Joubert et al. | South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides—A review | |
| Ma et al. | Extraction solvent affects the antioxidant, antimicrobial, cholinesterase and HepG2 human hepatocellular carcinoma cell inhibitory activities of Zanthoxylum bungeanum pericarps and the major chemical components | |
| CN103768151B (en) | Flos Osmanthi Fragrantis phenethyl alcohol glycoside extract is preparing the application in antiaging agent or health product | |
| Mudoi et al. | In vitro antioxidant activity of Garcinia pedunculata, an indigenous fruit | |
| Ding et al. | Chinese Propolis: Ultrasound‐assisted enhanced ethanolic extraction, volatile components analysis, antioxidant and antibacterial activity comparison | |
| Huang et al. | Effects of water solutions on extracting green tea leaves | |
| Muangrat et al. | Physicochemical properties and antioxidant activity of oil extracted from Assam tea seeds (Camellia sinensis var. assamica) by supercritical CO2 extraction | |
| CN104957512A (en) | Starch-removed high-oxidization-resistance monascus oat as well as preparation method and application thereof | |
| Oyeniran et al. | Comparative study of the phenolic profile, antioxidant properties, and inhibitory effects of Moringa (Moringa oleifera Lam.) and Almond (Terminalia catappa Linn.) leaves on acetylcholinesterase and monoamine oxidase activities in the head region of Fruitfly (Drosophila melanogaster Meigen) in vitro | |
| CN103145776A (en) | Gastrodin extraction method, preparation method of gastrodia elata soft capsules and soft capsules obtained by preparation method | |
| Wang et al. | Comparison of antioxidant and antibacterial activities of camellia oil from Hainan with camellia oil from Guangxi, olive oil, and peanut oil | |
| Gan et al. | Our tea-drinking habits: Effects of brewing cycles and infusion time on total phenol content and antioxidants of common teas | |
| Bao et al. | The current situation of Zanthoxylum bungeanum industry and the research and application prospect. A review | |
| KR100844185B1 (en) | The manfacturing method of fermentation artemisia tea with lactic acid | |
| CN102614099B (en) | Method for preparing rose extract for supercritical CO2 extraction cosmetics | |
| CN103222486B (en) | Plant extract with inhibiting effect on orange pathogenic bacteria as well as preparation method and application thereof | |
| CN105559074B (en) | A kind of tealeaves volatile essential oil is preparing the application in cancer-preventing health product or anticancer drug | |
| Yadav et al. | Phenolic profile and antioxidant activity of thermally processed sponge gourd (Luffa cylindrica) as studied by using high performance thin layer chromatography (HPTLC) | |
| CN104839450A (en) | Extract and application thereof as feed additive | |
| Majetić Germek et al. | Phenolic composition of Croatian olive leaves and their infusions obtained by hot and cold preparation | |
| Kusumawati et al. | The effect of extraction methods on total phenolic, flavonoid and antioxidant capacity of Loloh Sembung (Blumea balsamifera). | |
| KR102050663B1 (en) | Manufacturing method of makgeolli containing cockscomb extract | |
| Koczka et al. | Total phenolic content and antioxidant capacity of ginkgo teas | |
| Bansode | Total flavonoid content of commonly consumed teas in India |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |